<DOC>
	<DOCNO>NCT00787826</DOCNO>
	<brief_summary>This study design determine safety immunogenicity Live Francisella tularensis Vaccine</brief_summary>
	<brief_title>Continued Safety Immunogenicity Study Live Francisella Tularensis Vaccine</brief_title>
	<detailed_description>Study Objectives : 1 . To assess safety live F. tularensis vaccine NDBR 101 . 2 . To assess immunogenicity live F. tularensis vaccine NDBR 101 .</detailed_description>
	<mesh_term>Tularemia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . At least 18 year old . 2 . Females childbearing potential must agree urine serum pregnancy test vaccination day , immediately vaccination ( Exception : documented hysterectomy &gt; 3 year menopause ) . The result must negative . Subjects must agree become pregnant 3 month receipt vaccine . 3 . Subjects must risk exposure F. tularensis . 4 . Subjects must uptodate ( within 1 year ) medical history include concomitant medication , physical examination , laboratory test chart medically clear participation investigator . 5 . Subject must willing return followup visit day 1 2 , day 59 , 1216 , 2835 , 5684 ( need ) , visit serology , closeout interview 6 month ( Â±14 day ) vaccination revaccination . 6 . Subject must agree report adverse event may may associate administration test article least 28 day vaccination . 1 . Over age 65 Years . 2 . Vaccinated tularemia within last 10 year document , confirm tularemia infection . 3 . Clinically significant abnormal lab result include evidence hepatitis C , hepatitis B carrier state , elevate liver function test ( two time normal range discretion PI ) . 4 . Personal history immunodeficiency current treatment oral intravenous immunosuppressive medication . 5 . Confirmed HIV* infection . 6 . A medical condition , judgment Principal Investigator ( PI ) , would impact subject safety . 7 . Antibiotic therapy within 7 day vaccination . 8 . Pregnancy lactation . Subjects must agree become pregnant 3 month receipt vaccine . 9 . Any known allergy component vaccine : Modified casein partial hydrolysate medium Glucose cysteine hemin agar Sucrose gelatin agar stabilizer 10 . Administration another vaccine within 4 week tularemia vaccination . 11 . Any unresolved AE result previous immunization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Live Vaccine Strain ( LVS )</keyword>
</DOC>